Yahoo
OTC Markets OTCQB - Delayed Quote USD

Pharma-Bio Serv, Inc. (PBSV)

0.4000 -0.0500 (-11.11%)
At close: November 6 at 4:00:00 PM EST

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Victor Sanchez
CEO, President & President of European Operations 245.9k -- 1971
Mr. Pedro J. Lasanta
CFO, VP of Finance & Administration and Secretary 175.6k -- 1960
Ms. Miriam Marrero M.B.A.
Human Resources Manager -- -- --

Pharma-Bio Serv, Inc.

PO Box 1049
Dorado, PR 00646
United States
787 278 2709 https://www.pbsvinc.com
Sector: 
Healthcare
Full Time Employees: 
55

Description

Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and process support. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.

Corporate Governance

Pharma-Bio Serv, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

September 14, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

June 15, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 15, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 16, 2026 at 12:00 AM UTC

ARS: Annual Report to Shareholders

March 20, 2026 at 12:00 AM UTC

Dividend Date

March 17, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

February 27, 2026 at 12:00 AM UTC

10-K/A: Periodic Financial Reports

February 27, 2026 at 12:00 AM UTC

Ex-Dividend Date

January 29, 2026 at 12:00 AM UTC

10-K: Periodic Financial Reports

September 15, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: